Enantioseparation of Mirabegron Using Cyclodextrin-based Chiral Columns: High-performance Liquid Chromatography and Molecular Modeling Study. [PDF]
Mhammad A +5 more
europepmc +1 more source
Efficacy of the combination of transcutaneous tibial nerve stimulation and mirabegron in women with overactive bladder in a prospective randomized controlled trial. [PDF]
Xu YX +5 more
europepmc +1 more source
Mirabegron treatment reduces myofibroblasts and CXCR2 expression in adipose tissue in obesity. [PDF]
Finlin BS +5 more
europepmc +1 more source
Kabbe condensation: a comprehensive review of spirochromanone synthesis and medicinal applications. [PDF]
Samandram R +6 more
europepmc +1 more source
Is the Addition of CO<sub>2</sub> Laser to β3-Adrenoceptor Agonist Mirabegron Effective in the Management of Overactive Bladder? Results of a Randomized Controlled Trial. [PDF]
Kypriotis K +8 more
europepmc +1 more source
An Integrated Review of Pesticides and Antibiotics in Agricultural Environments: Occurrence, Cross-Media Transport, and Plant Uptake. [PDF]
Li J, Yan Q, Du B, Feng G.
europepmc +1 more source
Mirabegron nighttime versus daytime dosing for women with overactive bladder syndrome: a randomized controlled trial. [PDF]
Hsiao SM.
europepmc +1 more source
Pre-Steady-State and Steady-State Kinetic Analysis of Butyrylcholinesterase-Catalyzed Hydrolysis of Mirabegron, an Arylacylamide Drug. [PDF]
Shaihutdinova Z, Masson P.
europepmc +1 more source
7-Methoxybenzofuran-triazole tethered <i>N</i>-phenylacetamides as a promising class of tyrosinase inhibitors: synthesis, biological evaluation and computational analyses against fungal and human tyrosinases. [PDF]
Mushtaq A +5 more
europepmc +1 more source
Drug-induced xerostomia and hyposalivation in patients with overactive bladder: a prospective open-label observational study comparing antimuscarinics and β3-adrenoceptor agonists. [PDF]
Ostrowska M +6 more
europepmc +1 more source

